Clinical Trial

Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia

Name: Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia — clinical trial record (NCT07298824)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To investigate whether probiotic MR-61 can assist in slowing down the progression rate of myopia (a prospective randomized controlled study).

Trial Details

NCT Number	NCT07298824
Lead Sponsor	Second Affiliated Hospital of Nanchang University
Conditions	Myopia Progressing
Enrollment	164 participants
Start Date	2025-10-01
Primary Completion	2027-07-01 (estimated)
Study Completion	2027-07-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-23